Zavzpret Spray
Product Images NDC 63539-135

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Zavzpret (NDC 63539-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zavegepant 01)

FDA Label Image

Figure 1 (Zavegepant 02)

FDA Label Image

Figure 2 (Zavegepant 03)

FDA Label Image

Figure 3 (Zavegepant 04)

FDA Label Image

Figure 4 (Zavegepant 05)

FDA Label Image

Logo (Zavegepant 06)

Stfier is a product distributed by Pfizer Labs, which is a division of Pfizer Inc. based in New York, NY 10001.*

FDA Label Image

Logo (Zavegepant 07)

"Stfier" appears to be a not-available text as it does not provide any useful information. However, "Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10001" indicates that the product named "Stfier" is distributed by Pfizer Labs which is a division of Pfizer Inc. located in New York City.*

FDA Label Image

Figure A (Zavegepant 08)

FDA Label Image

Figure B (Zavegepant 09)

FDA Label Image

Figure C (Zavegepant 10)

FDA Label Image

Figure D (Zavegepant 11)

FDA Label Image

Figure E (Zavegepant 12)

FDA Label Image

Figure F (Zavegepant 13)

FDA Label Image

Figure G (Zavegepant 14)

FDA Label Image

Figure H (Zavegepant 15)

FDA Label Image

Figure I (Zavegepant 16)

FDA Label Image

Figure J (Zavegepant 17)

FDA Label Image

Figure K (Zavegepant 18)

The text suggests a breathing exercise to be done for 10-20 seconds, involving inhaling through the nose and exhaling through the mouth. Figure K may provide further context or visualization for the exercise.*

FDA Label Image

Figure L (Zavegepant 19)

FDA Label Image

Logo (Zavegepant 20)

Stfier is a product that is distributed by Pfizer Labs which is a division of Pfizer Inc. The physical location of Pfizer Inc. is in New York, NY 10001.*

FDA Label Image

Principal Display Panel – Nasal Spray Device Label Front Sample (Zavzpret 07)

FDA Label Image

Principal Display Panel – Nasal Spray Device Label Back Sample (Zavzpret 08)

The text refers to Pfizer Inc., a U.S. pharmaceuticals company. However, the number 141392 doesn't provide any context or information to generate a useful description.*

FDA Label Image

Principal Display Panel – Nasal Spray Blister Foil Label Sample (Zavzpret 09)

This is a professional sample of nasal spray labeled NDC 63539-135-01 containing 10mg of zavegepant per unit-dose. The product is for intranasal use only and should not be sprayed, primed, or press before use. Recommended dosage should be taken as per the prescribing information. The device should be stored at a temperature range of 20°C to 25°C, and it should be kept in the sealed blister package. The product is not intended for sale, and the label cautions against keeping it within children's reach. The distributor is P.U.S Pharmaceuticals, a division of Pfizer Inc. based in New York, NY.*

FDA Label Image

Principal Display Panel – Nasal Spray Carton Sample (Zavzpret 10)

ZAVZPRET (zavegepant) is a professional-use nasal spray containing 10 mg of zavegepant. Each unit-dose spray delivers 10 mg of zavegepant free base (equivalent to 10.6 mg of zavegepant hydrochloride) in an aqueous buffered solution containing dextrose, hydrochloric acid, sodium hydroxide, and succinic acid in water for injection. The recommended dosage and storage as well as warnings and instructions for use are provided on the package and the enclosed leaflet. For more information, visit zavzpret.com or call 1-800-436-1985. The product is not intended for sale. GTIN 0363539135026.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.